Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Terns Pharmaceuticals (NASDAQ: TERN), a clinical-stage biopharmaceutical company focused on developing small-molecule treatments for oncology and obesity, has announced its participation in two major investor conferences in June 2025:

The Jefferies Global Healthcare Conference on June 5, 2025, at 11:05 a.m. ET in New York City
The Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025, at 4:00 p.m. ET in Miami

Both presentations will be in a fireside chat format and will be available via webcast on the company's investor relations website, with replays accessible for at least 30 days after the events.

05/29/2025 - 04:05 PM

FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in the following upcoming investor conferences in June.

Jefferies Global Healthcare Conference
Format: Fireside Chat
Date and Time: Thursday, June 5, 2025 at 11:05 a.m ET
Location: New York City

Goldman Sachs 46^th Annual Global Healthcare Conference
Format: Fireside Chat
Date and Time: Monday, June 9, 2025 at 4:00 p.m. ET
Location: Miami

Live webcasts of the fireside chats will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentations.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist, and a preclinical GIPR modulator discovery effort, prioritizing a GIPR antagonist nomination candidate. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Kaytee Bock Zafereo
investors@ternspharma.com

Media
Jenna Urban
CG Life
media@ternspharma.com

FAQ

When is Terns Pharmaceuticals (TERN) presenting at the Jefferies Healthcare Conference 2025?

Terns Pharmaceuticals will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 11:05 a.m ET in New York City.

What time is TERN's presentation at the Goldman Sachs Healthcare Conference 2025?

Terns Pharmaceuticals will present at the Goldman Sachs Global Healthcare Conference on Monday, June 9, 2025, at 4:00 p.m. ET in Miami.

Where can I watch Terns Pharmaceuticals' (TERN) June 2025 investor conference presentations?

The presentations will be available via live webcast on Terns Pharmaceuticals' investor relations website at http://ir.ternspharma.com, with replays available for at least 30 days.